These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 34779088)

  • 1. Report of two cases of minimal change disease following vaccination for COVID -19.
    Baskaran K; Cohen AWS; Weerasinghe N; Vilayur E
    Nephrology (Carlton); 2022 Jan; 27(1):111-112. PubMed ID: 34779088
    [No Abstract]   [Full Text] [Related]  

  • 2. Minimal change disease and acute interstitial nephritis following SARS-CoV-2 BNT162b2 vaccination.
    Jongvilaikasem P; Rianthavorn P
    Pediatr Nephrol; 2022 Jun; 37(6):1419-1421. PubMed ID: 35132446
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe immune thrombocytopenia after COVID-19 vaccination: Report of four cases and review of the literature.
    Gardellini A; Guidotti F; Maino E; Steffanoni S; Zancanella M; Turrini M
    Blood Cells Mol Dis; 2021 Dec; 92():102615. PubMed ID: 34653943
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety of anti-SARS-CoV-2 vaccination for patients with immune thrombocytopenia.
    Crickx E; Moulis G; Ebbo M; Terriou L; Briantais A; Languille L; Limal N; Guillet S; Michel M; Mahevas M; Godeau B
    Br J Haematol; 2021 Dec; 195(5):703-705. PubMed ID: 34467525
    [No Abstract]   [Full Text] [Related]  

  • 5. Gross haematuria after mRNA COVID-19 vaccination in two patients with histological and clinical diagnosis of IgA nephropathy.
    Lo WK; Chan KW
    Nephrology (Carlton); 2022 Jan; 27(1):110-111. PubMed ID: 34766415
    [No Abstract]   [Full Text] [Related]  

  • 6. Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA-based or adenoviral vector-based SARS-CoV-2 vaccination.
    Kreuter A; Licciardi-Fernandez MJ; Burmann SN; Burkert B; Oellig F; Michalowitz AL
    Clin Exp Dermatol; 2022 Jan; 47(1):161-163. PubMed ID: 34291477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Responses to the ChAdOx1 nCoV-19 and BNT162b2 Vaccines and to Natural Coronavirus Disease 2019 Infections Over a 3-Month Period.
    Kim JY; Lim SY; Park S; Kwon JS; Bae S; Park JY; Cha HH; Seo MH; Lee HJ; Lee N; Kim K; Shum D; Jee Y; Kim SH
    J Infect Dis; 2022 Mar; 225(5):777-784. PubMed ID: 34850034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombocytopenia after COVID-19 vaccination.
    Kragholm K; Sessa M; Mulvad T; Andersen MP; Collatz-Christensen H; Blomberg SN; Lippert F; Mikkelsen S; Leutscher P; Melgaard D; Torp-Pedersen C; Kristensen SR; Larsen TB; Sogaard P
    J Autoimmun; 2021 Sep; 123():102712. PubMed ID: 34332437
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19 timeline of events.
    Webster P
    Nat Med; 2021 Dec; 27(12):2054-2055. PubMed ID: 34907389
    [No Abstract]   [Full Text] [Related]  

  • 10. Relapsed ANCA associated vasculitis following Oxford AstraZeneca ChAdOx1-S COVID-19 vaccination: A case series of two patients.
    David R; Hanna P; Lee K; Ritchie A
    Nephrology (Carlton); 2022 Jan; 27(1):109-110. PubMed ID: 34755433
    [No Abstract]   [Full Text] [Related]  

  • 11. Isolated thrombosis after COVID-19 vaccination: case series.
    Al-Ahmad M; Al Rasheed M; Altourah L; Rodriguez-Bouza T; Shalaby N
    Int J Hematol; 2022 Feb; 115(2):153-157. PubMed ID: 34993889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guillain-Barre Syndrome After Two COVID-19 Vaccinations: Two Case Reports With Follow-up Electrodiagnostic Study.
    Kim JW; Kim YG; Park YC; Choi S; Lee S; Min HJ; Kim MJ
    J Korean Med Sci; 2022 Feb; 37(7):e58. PubMed ID: 35191234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism Registry.
    Bikdeli B; Jiménez D; Demelo-Rodriguez P; Galeano-Valle F; Porras JA; Barba R; Ay C; Malý R; Braester A; Imbalzano E; Rosa V; Lecumberri R; Siniscalchi C; Fidalgo Á; Ortiz S; Monreal M; For The Riete Investigators
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effectiveness and safety of homologous two-dose ChAdOx1 versus heterologous vaccination with ChAdOx1 and BNT162b2.
    Hermosilla E; Coma E; Xie J; Feng S; Cabezas C; Méndez-Boo L; Fina F; Ballo E; Martínez M; Medina-Peralta M; Argimon JM; Prieto-Alhambra D
    Nat Commun; 2022 Mar; 13(1):1639. PubMed ID: 35322045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Thrombocytopenia (ITP): Relapse Versus de novo After COVID-19 Vaccination.
    Al-Ahmad M; Al Rasheed M; Shalaby N; Rodriguez-Bouza T; Altourah L
    Clin Appl Thromb Hemost; 2022; 28():10760296211073920. PubMed ID: 35108113
    [No Abstract]   [Full Text] [Related]  

  • 16. Phenotypic spectrum of serious cutaneous-only adverse event following immunization with COVID-19 vaccines: a multicentre case series and literature review.
    Balogun M; Millette D; Yip V; Chan SA; Lee P; Gamal N; Hashim N; Phillips D; Walsh M; Trehan P; Hanna-Bashara L; Abdullah A; Wernham A; Tso S
    Clin Exp Dermatol; 2022 Mar; 47(3):614-616. PubMed ID: 34748655
    [No Abstract]   [Full Text] [Related]  

  • 17. Kinetics of the Antibody Response to Boostering With Three Different Vaccines Against SARS-CoV-2.
    Markewitz R; Juhl D; Pauli D; Görg S; Junker R; Rupp J; Engel S; Steinhagen K; Herbst V; Zapf D; Krüger C; Brockmann C; Leypoldt F; Dargvainiene J; Schomburg B; Sharifzadeh S; Nejad LS; Wandinger KP; Ziemann M
    Front Immunol; 2022; 13():811020. PubMed ID: 35126395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants.
    Groß R; Zanoni M; Seidel A; Conzelmann C; Gilg A; Krnavek D; Erdemci-Evin S; Mayer B; Hoffmann M; Pöhlmann S; Liu W; Hahn BH; Beil A; Kroschel J; Jahrsdörfer B; Schrezenmeier H; Kirchhoff F; Münch J; Müller JA
    EBioMedicine; 2022 Jan; 75():103761. PubMed ID: 34929493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine: two cases.
    Hartley JL; Bailey N; Sharma A; Shawki H
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35246429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can families believe the accuracy of websites' information regarding COVID-19 vaccines' side effects?
    Harvey-Nguyen L; Tuthill D
    Arch Dis Child; 2022 Mar; 107(3):e24. PubMed ID: 34906965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.